Co-Diagnostics, Inc. CODX
$1.14
$0.032.70%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -9.19% | -9.46% | -45.69% | -24.86% | -5.96% |
| Total Other Revenue | -52.96% | -93.03% | -93.50% | -100.00% | -94.91% |
| Total Revenue | -28.12% | -79.47% | -84.10% | -93.06% | -89.02% |
| Cost of Revenue | -32.73% | -49.81% | -77.74% | -90.97% | -83.48% |
| Gross Profit | -21.11% | -88.07% | -86.28% | -95.21% | -92.73% |
| SG&A Expenses | -47.71% | -43.94% | -44.58% | -21.39% | -5.12% |
| Depreciation & Amortization | -22.49% | -18.48% | -19.63% | -10.26% | 0.16% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -22.52% | -22.00% | -27.48% | -23.84% | -16.89% |
| Operating Income | 22.37% | 16.77% | 21.95% | 11.17% | -0.13% |
| Income Before Tax | -35.39% | -39.97% | -29.08% | 10.84% | -0.41% |
| Income Tax Expenses | -4,331.33% | -3,592.49% | -2,915.33% | -129.50% | -97.83% |
| Earnings from Continuing Operations | -30.74% | -35.25% | -24.59% | 22.05% | 4.20% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -30.74% | -35.25% | -24.59% | 22.05% | 4.20% |
| EBIT | 22.37% | 16.77% | 21.95% | 11.17% | -0.13% |
| EBITDA | 22.37% | 16.70% | 22.03% | 11.20% | -0.13% |
| EPS Basic | 30.52% | 15.74% | 12.91% | 28.92% | 9.66% |
| Normalized Basic EPS | 58.90% | 43.02% | 35.91% | 16.52% | 3.29% |
| EPS Diluted | 30.35% | 15.63% | 12.84% | 28.57% | 9.39% |
| Normalized Diluted EPS | 58.90% | 43.02% | 35.91% | 16.52% | 3.29% |
| Average Basic Shares Outstanding | 130.23% | 57.93% | 31.50% | 11.67% | 6.51% |
| Average Diluted Shares Outstanding | 130.23% | 57.93% | 31.50% | 11.67% | 6.51% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |